Daunorubicin (Liposomal) and Insulin Degludec (U-100) Vials
Determining the interaction of Daunorubicin (Liposomal) and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daunorubicin liposomal
Brand name: DaunoXome
Synonyms: DAUNOrubicin (Liposomal)
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin (Liposomal)-Insulin Degludec (U-200) Prefilled Pens
- Daunorubicin (Liposomal)-Insulin degludec and liraglutide
- Daunorubicin (Liposomal)-Insulin degludec and liraglutide Subcutaneous
- Daunorubicin (Liposomal)-Insulin degludec Subcutaneous
- Daunorubicin (Liposomal)-Insulin detemir
- Daunorubicin (Liposomal)-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-DAUNOrubicin and Cytarabine
- Insulin Degludec (U-100) Vials-Daunorubicin and Cytarabine (Liposomal)
- Insulin Degludec (U-100) Vials-Daunorubicin and cytarabine liposome Intravenous
- Insulin Degludec (U-100) Vials-Daunorubicin citrate
- Insulin Degludec (U-100) Vials-Daunorubicin citrate liposome Intravenous
- Insulin Degludec (U-100) Vials-Daunorubicin hydrochloride